Orion Pharma — origin, manufacturing and ownership

Orion Pharma is the trade name used by Orion Corporation (Orion Oyj), a Finnish pharmaceutical company founded in 1917 and headquartered in Espoo, Finland. The brand and company originate in Finland and have grown into an international R&D-led pharmaceutical group focused on human and veterinary medicines, active pharmaceutical ingredients (APIs) and self-care products.

Manufacturing and geographic footprint

Orion's manufacturing footprint is primarily in Finland — the company historically locates the majority of its production sites and R&D units in Finland — while also operating additional production and sales operations in other European locations (for example sites reported in Belgium and France) and sales organisations across Europe, Asia and other regions. In short: manufacturing is primarily in Finland, but Orion also produces and distributes products from other locations.

Ownership and corporate structure

Orion Corporation is a publicly listed company (Nasdaq Helsinki) and is the ultimate owner of the Orion Pharma brand. It was originally created by Finnish pharmacists in 1917 and remains an independent corporate entity rather than a subsidiary of another pharmaceutical conglomerate. The company operates through multiple national subsidiaries and distribution partners for local marketing and sales; these subsidiaries handle local registration, distribution and sales but do not represent separate ultimate ownership.

Key business focus

Orion is an R&D-driven firm with core therapy areas that have included central nervous system (CNS) disorders, oncology and respiratory diseases, and it produces medicines, inhalation products, self-care liquids and APIs. The company combines in-house manufacturing (mostly in Finland) with international sales and partnership agreements to reach global markets.